<?xml version="1.0"?>
<Ontology xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.semanticweb.org/priyanka/ontologies/2018/11/breastCancer#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     ontologyIRI="http://www.semanticweb.org/priyanka/ontologies/2018/11/breastCancer#">
    <Prefix name="owl" IRI="http://www.w3.org/2002/07/owl#"/>
    <Prefix name="rdf" IRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#"/>
    <Prefix name="xml" IRI="http://www.w3.org/XML/1998/namespace"/>
    <Prefix name="xsd" IRI="http://www.w3.org/2001/XMLSchema#"/>
    <Prefix name="rdfs" IRI="http://www.w3.org/2000/01/rdf-schema#"/>
    <Declaration>
        <Class IRI="Chemical"/>
    </Declaration>
    <Declaration>
        <Class IRI="Disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="Mutation"/>
    </Declaration>
    <Declaration>
        <Class IRI="Species"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="promiseforfuturedevelopment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="combinatorialanti-proliferativeeffectson"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="couldoptimizepatientselectionin"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="expressionof"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="resultingin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tumorgrowthreductioninEgKI-1-treatedmice"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Thereforeselecting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="3Dphantom"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="vary"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="initiationofchemotherapylongtermsurvivaldataarelacking"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="progressionofbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellcycle"/>
    </Declaration>
    <Declaration>
        <Class IRI="womenwithBCstreatedfrom2008to2017"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="downregulatedIRswith"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="canlose"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="oncosphereofcaninetapewormEchinococcus"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aqueousOrthosiphonpallidusextract"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tumorgrowthreduction"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="supplying"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="activityinin-vitromodels"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="effectson"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wereenrolledin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="phantom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="preparations"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="washighbetween"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="adjuvantacceleratedbreastirradiation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="HRpositivebreastcancerPI3Kinhibitors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="appointment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="poweractivities"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="significantlyimproves"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wassignificantlyhigherin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="anthracycline-basedadjuvanttherapies"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Theirtreatment-relatedcosmeticchanges"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="retrospectivestudy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="combinationtherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="diagnosis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="pivotalroleonIRsignallinginMCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="selectiveestrogenreceptormodulators"/>
    </Declaration>
    <Declaration>
        <Class IRI="SOX4promoter"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="functionas"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Breastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="investigate"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="reducing"/>
    </Declaration>
    <Declaration>
        <Class IRI="evenpresenceofinsulin"/>
    </Declaration>
    <Declaration>
        <Class IRI="IRantagonistS961"/>
    </Declaration>
    <Declaration>
        <Class IRI="utilizationforbreastcancertherapyviadisruption"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="damage"/>
    </Declaration>
    <Declaration>
        <Class IRI="novelutilizationof3-O-p-coumaroyltormenticacidforbreastcancertherapyviadisruption"/>
    </Declaration>
    <Declaration>
        <Class IRI="co-treatmentoftamoxifen"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="werecomparedacross"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isexpressedby"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Itspotentialpracticalapplications"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="predicting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="developmentoftumors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="voxel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±transcriptioncycle"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="chromatographicpreparations"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="advancedbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="activates"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="MTT"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="supportivecareallowing"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="using"/>
    </Declaration>
    <Declaration>
        <Class IRI="naringenintreatmentgroup"/>
    </Declaration>
    <Declaration>
        <Class IRI="women"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="excellent/good"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="arecomputedfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Patientself-reports"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="proliferation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="expressing"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="beforewastakenfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="brachytherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="investigated"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="importantgrowthpathway"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highrecurrencerisk"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellularproliferationinbreasttumourcells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="backboneoftreatment"/>
    </Declaration>
    <Declaration>
        <Class IRI="Other"/>
    </Declaration>
    <Declaration>
        <Class IRI="Women&apos;sSexualFunction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="QPCRscreening"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="gene"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrenceriskbeyond5years"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="adjuvantacceleratedpartialbreastirradiation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="endocrinetherapyresistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="related"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="EgKI-1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="convolutionbetweenarterialinputfunction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="OPAEconcentrationupto240g/mL"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="GEM"/>
    </Declaration>
    <Declaration>
        <Class IRI="ERcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="differentenhancementdynamics"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±polyubiquitinationestrogenreceptordegraders"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasAt"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="perfusionindifferenttypesofbreastlesions"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="reductioninbreastcancergrowth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalclinicopathologicalparameters"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="upregulatedexpression"/>
    </Declaration>
    <Declaration>
        <Class IRI="tamoxifen"/>
    </Declaration>
    <Declaration>
        <Class IRI="recurrencesinpatients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="deaths"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="couldprovide"/>
    </Declaration>
    <Declaration>
        <Class IRI="cancerprevention"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="responsivegene"/>
    </Declaration>
    <Declaration>
        <Class IRI="4patients"/>
    </Declaration>
    <Declaration>
        <Class IRI="51.1%ofpatientsG2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="averagetime"/>
    </Declaration>
    <Declaration>
        <Class IRI="3patients"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="shows"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancercellproliferation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="hadundergone"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="significanttumorgrowthreduction"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="review"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="roleonIRsignallinginMCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inhibitsmigrationin"/>
    </Declaration>
    <Declaration>
        <Class IRI="5yearsoftamoxifentherapywith5yearsoftamoxifen"/>
    </Declaration>
    <Declaration>
        <Class IRI="Japanesepatientswithmetastaticbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="oncosphere"/>
    </Declaration>
    <Declaration>
        <Class IRI="reductioninbreastcancergrowth"/>
    </Declaration>
    <Declaration>
        <Class IRI="percentcytotoxicity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="co-treatment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Long-termintervention"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="IRsignalling"/>
    </Declaration>
    <Declaration>
        <Class IRI="laterecurrencesinpatientswithtumors"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="reduces"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cyclindependentkinase"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aspectsofmalignantphenotypeincludingcellproliferation"/>
    </Declaration>
    <Declaration>
        <Class IRI="CXCL1silencing"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Femalepatients"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="affecting"/>
    </Declaration>
    <Declaration>
        <Class IRI="laterecurrencesinpatients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ubiquitinproteasomesystem"/>
    </Declaration>
    <Declaration>
        <Class IRI="tumorgrowthreductioninmice"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Enhancedunderstanding"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="idealstrategy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="varyperfusionparameterson"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ER-positive/humanepidermalgrowthfactorreceptor2-negativebreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="growthpathwayinHRpositivebreastcancerPI3Kinhibitors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="targets"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="anti-cancertherapeutic"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="agents"/>
    </Declaration>
    <Declaration>
        <Class IRI="womenwithHER2-positiveBCstreatedwithtrastuzumabfrom2008to2017"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="doses"/>
    </Declaration>
    <Declaration>
        <Class IRI="informationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="prognosisdiscussioncommunicationskills"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="estrogenreceptor"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="arein"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="growthpathway"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="sequencing"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="ofdosesis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="highexpressionof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="enhancementdynamics"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="threedifferentmetricsofmortality"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="therapeutictargets"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="G2/Mphase"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="potentialbiomarkers"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Level1doses"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="514women"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="managementchallenges"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="combinationwithotherchemotherapeuticagents"/>
    </Declaration>
    <Declaration>
        <Class IRI="patient"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="feasibilityof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±degradation"/>
    </Declaration>
    <Declaration>
        <Class IRI="developmentofmammarytumors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastCTimage"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="hold"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="15fractionsfordose"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="significantreductioninbreastcancergrowth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="transcription"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="potentialbiomarkersofresistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="majority"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="member"/>
    </Declaration>
    <Declaration>
        <Class IRI="significanttumorgrowthreductioninEgKI-1-treatedmice"/>
    </Declaration>
    <Declaration>
        <Class IRI="tumormodels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalparameters"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isrelatedto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="increaseinERÎ±proteinlevels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="4DbreastCTimageacquisition"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="OPAEconcentration"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="adjuvantpartialbreastirradiation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="VMAT-SIBtechnique"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="threevisualrepresentations"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="additivemanner"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="CD44high/CD24lowsubpopulation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="islinked"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcosmesis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="uniformrandomdistribution"/>
    </Declaration>
    <Declaration>
        <Class IRI="patientswithtumorsshowing"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="total"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancergrowth"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="apoptosisof"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="hasdimensionsAs"/>
    </Declaration>
    <Declaration>
        <Class IRI="CXCL1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aldehydedehydrogenase"/>
    </Declaration>
    <Declaration>
        <Class IRI="progressionofbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="naringenintreatmentgroup"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosiswithbreastCT."/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="genes"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="hasledto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancerpatients"/>
    </Declaration>
    <Declaration>
        <Class IRI="tumorgrowthreduction"/>
    </Declaration>
    <Declaration>
        <Class IRI="roleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ALDH"/>
    </Declaration>
    <Declaration>
        <Class IRI="selectiveestrogenreceptormodulators"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="issignificantlycorrelatedwith"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±polyubiquitinationselectiveestrogenreceptordegraders"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="metastaticbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="activities"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="potentactivity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="backboneincases"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="repeatedchromatographicpreparations"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highestresponsivegene"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="expressionofmitochondrialapoptoticproteins"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breast"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="polyubiquitination"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="penetrationpaindesirelubrication"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="epithelial-mesenchymaltransition"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="functionalinformation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ImmediateVerbalMemoryIndex"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="utilizationforbreastcancertherapyviadisruption"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="resultsin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="IRoverexpression"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="compound"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="waschangedin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Iclinicalstudy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="influencefunctionwith"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="regulates"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="antagonism"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="closedloopstructure"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="benefitfromextendedendocrinetherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="clinicians"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="groupAB"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cognitivedecline"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inhibited"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="mainproblems"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="validatedSOX4following"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="distinctantagonism"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="soonwasrestoredafter"/>
    </Declaration>
    <Declaration>
        <Class IRI="MTT"/>
    </Declaration>
    <Declaration>
        <Class IRI="advancedbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="patientselection"/>
    </Declaration>
    <Declaration>
        <Class IRI="otherpatients"/>
    </Declaration>
    <Declaration>
        <Class IRI="significanttumorgrowthreduction"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="areprognosticfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="extensivegrowth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERI"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="expectedenhancementoftissuesconsistentwithgiveninputparameters"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="promotes"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="problems"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="nanomolardose"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="relatedtotherapyresistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="continuedpresence"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inducedapoptosisof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="4patients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±polyubiquitination"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="second-leadingcauseof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="treatmentcessation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="delay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrencesinpatientswithtumors"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasappliedon"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="increasewith"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="treatmentofadvancedHRpositiveHER2negativebreastcancerhighlighting"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="allowing"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inhibitedcellproliferationin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="WMS-Rindicesbetweentwostudies"/>
    </Declaration>
    <Declaration>
        <Class IRI="womenwithHER2-positiveBCstreatedwithtrastuzumab"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isknown"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tumorsshowing"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="alsofunctionas"/>
    </Declaration>
    <Declaration>
        <Class IRI="plasmaIL-6levels"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Extending"/>
    </Declaration>
    <Declaration>
        <Class IRI="GEM"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="in-vitromodels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="perfusionparameters"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="segmenting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="laterecurrencesinpatients"/>
    </Declaration>
    <Declaration>
        <Class IRI="ERÎ±polyubiquitinationestrogenreceptordegraders"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="mRNAexpression"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tamoxifen"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="disappearedafter"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Moreoverisrelatedto"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="segmentingbreastCTimagefrom"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="ledto"/>
    </Declaration>
    <Declaration>
        <Class IRI="cancercells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="hormonereceptor"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="iscorrelatedwith"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="celllines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="3patients"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancercellproliferation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasrestoredafter"/>
    </Declaration>
    <Declaration>
        <Class IRI="T-PATparticipants"/>
    </Declaration>
    <Declaration>
        <Class IRI="Patientself-reports"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="advancedrecurrentbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastirradiation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="endofRTtreatmentskintoxicity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="futurestudies"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Itspotentialapplications"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wererecordedon"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellmigration"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="coactivatorsforERÎ±"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="trainees"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="assess"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastconservationtherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="acceleratedpartialbreastirradiation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inhibitsbreastcancercellproliferationin"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="upregulatedexpressionof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="curves"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="showing"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="existingin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="TAMs"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="washigherin"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="indiagnosisis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aspects"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="laterecurrences"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="humancelllines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="potentactivityinin-vitromodels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="proposedphantom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="dysfunctions"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="expressionofself-renewal-relatedgenes"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="predicting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="specificproteincomplexes"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="increasesteadilywith"/>
    </Declaration>
    <Declaration>
        <Class IRI="growthpathwayinHRpositivebreastcancerPI3Kinhibitors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tumorgrowthreductioninmice"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="IRs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="TheDelayed"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="ofpatientis"/>
    </Declaration>
    <Declaration>
        <Class IRI="ER-positive/humanepidermalgrowthfactorreceptor2-negativebreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="penetrationpain"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="evaluate"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isanticipated"/>
    </Declaration>
    <Declaration>
        <Class IRI="ERÎ±polyubiquitinationselectiveestrogenreceptordegraders"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="underlying"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="toleratedin"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="arestillrequiredfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="effects"/>
    </Declaration>
    <Declaration>
        <Class IRI="endofRTtreatmentskintoxicity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="research"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="expressionofIRs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="treatment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="roleonIRsignalling"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="bindsto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="twogroupsincluding196patients"/>
    </Declaration>
    <Declaration>
        <Class IRI="mouse"/>
    </Declaration>
    <Declaration>
        <Class IRI="singletamoxifen"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highCXCL1expression"/>
    </Declaration>
    <Declaration>
        <Class IRI="free-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="canreduce"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="free-radicalscavenging"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="5yearsoftamoxifentherapywith5yearsoftamoxifen"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellgrowthofMCF-7cellsathigherconcentrations"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Agreement"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="remainsfor"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Moreovershow"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="humanbreast-cancercelllines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breasttumourcells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Women&apos;sSexualFunction"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="included"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="expressionin"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasfoundin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="CXCL1silencing"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="surgery"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="ofageis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="instruments"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="SOX4promoter"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="dose"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="patientswithtumorsshowing"/>
    </Declaration>
    <Declaration>
        <Class IRI="estrogenreceptor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="seriousdamage"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="downregulated"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrenceriskbeyond5yearsafterdiagnosis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="backboneoftreatmentincases"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="womenwithHER2-positiveBCstreatedwithtrastuzumabfrom2008to2017"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancerpatients"/>
    </Declaration>
    <Declaration>
        <Class IRI="recurrencesinpatientswithtumors"/>
    </Declaration>
    <Declaration>
        <Class IRI="womenwithbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="co-treatmentoftamoxifen"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="partialbreastirradiation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="varyon"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="couldoptimize"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="improve"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="predominantlyexpressed"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="antioxidantfree-radicalscavengingagainst"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="arecalculatedby"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="continuedpresenceofS961"/>
    </Declaration>
    <Declaration>
        <Class IRI="tumorsshowing"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="proliferationowing"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastradiotherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="514women"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="normalcellgrowth"/>
    </Declaration>
    <Declaration>
        <Class IRI="patientswithhormonereceptor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="naringenin"/>
    </Declaration>
    <Declaration>
        <Class IRI="cancercellgrowth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="developmentofmammarytumors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="patient"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="proliferationinbreasttumourcells"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="weredueto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Japanesepatients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aspectsofmalignantphenotype"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Extendedendocrinetherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="events"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="primarysexualdysfunctions"/>
    </Declaration>
    <Declaration>
        <Class IRI="developmentofgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="rangedbefore"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="percentcytotoxicity"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="showed"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="VMAT-SIB"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Takentogether"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="increase"/>
    </Declaration>
    <Declaration>
        <Class IRI="significantreductioninbreastcancergrowth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="plannedprognosisdiscussion"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="canmodel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="therapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="investigation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="initiationofchemotherapylongtermoverallsurvivaldataarelacking"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="quantitativePCR"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="clinic"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="reduction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="wholebreast"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="effect"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="T-PATappointment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasmeasuredin"/>
    </Declaration>
    <Declaration>
        <Class IRI="Japanesepatients"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="received"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="arterialsources"/>
    </Declaration>
    <Declaration>
        <Class IRI="participants"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="S961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="data"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="anticanceractivitiesofO.pallidus"/>
    </Declaration>
    <Declaration>
        <Class IRI="treatmentofadvancedHRpositiveHER2negativebreastcancerhighlighting"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Howeverarerequiredfor"/>
    </Declaration>
    <Declaration>
        <Class IRI="mTORinhibitoreverolimus"/>
    </Declaration>
    <Declaration>
        <Class IRI="informationofbreastresultingindetectiondiagnosisofbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="varyonvoxel-basis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="werequestionnaireon"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="HRpositivemetastaticbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="furtherinvestigation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="womenwithHER2-positiveBCstreatedwithtrastuzumab"/>
    </Declaration>
    <Declaration>
        <Class IRI="humancelllines"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="suppressed"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Results"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="plasmaIL-6levels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="196patients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="HER2-positiveBCstreatedfrom2008to2017"/>
    </Declaration>
    <Declaration>
        <Class IRI="Mostpatients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="study"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="womenwithbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="ishighlyexpressedby"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="efficientlyblocked"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wereescalatedfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="transcriptionofcellcycleregulationproteins"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="relatedtoendocrinetherapyresistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Sexualfunction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellgrowthatconcentrations"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="dose-dependentmanner"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancerpathogenesis"/>
    </Declaration>
    <Declaration>
        <Class IRI="roleofIRantagonistS961onIRsignalling"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="otherpatients"/>
    </Declaration>
    <Declaration>
        <Class IRI="patientselection"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="type"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="digitalphantom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="pathway"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="informationofbreastresulting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="information"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="intraclasscorrelationcoefficient"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="maykeyfactor"/>
    </Declaration>
    <Declaration>
        <Class IRI="advancedrecurrentbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="outcomes"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="T-PATparticipants"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalaspectsofphenotypeincludingcellproliferation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cancer-relateddeath"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="isolation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellgrowth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="roleofIRantagonistS961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="setting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="posttranslationalmodificationsinteractions"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="effectiveness"/>
    </Declaration>
    <Declaration>
        <Class IRI="early-stagebreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="benefitfrom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="decline"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="develop"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="extranuclearactivity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="46.34Â±8.28years"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="only1patientofLevel1group"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="MCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="TargetingbreastCSCs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="3Dstaticphantom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="CXCL1administration"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="work"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="mightreduce"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="found"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="antioxidantfree-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="adjuvantbreastradiotherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancercells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="changes"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="promotesbreastcancermetastasisvia"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="dependson"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="perfusionparametersassociatedwithtissuevoxel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="humanepidermalgrowthfactorreceptor2"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="canmodelbreasttissueperfusionduring"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="repeatedpreparations"/>
    </Declaration>
    <Declaration>
        <Class IRI="healthypatientintoskinfibroglandulartissueadiposetissue"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="sufferingfrom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="typical4Dphantom"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="islinkedto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastlesionmodel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="PI3K/AKT/mTORpathway"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="coregulatorsofspecificproteincomplexes"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancerlymphnodemetastasis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="expressed"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="evaluatedin"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="resultingvia"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Extendedtherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isused"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="combinedtreatmentof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="free-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="loop"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="mouse"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="continue"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cosmeticoutcomes"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highexpressionofestrogen-responsivegenes"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="clinicopathologicalparameters"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellproliferation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="alsoinhibited"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasin"/>
    </Declaration>
    <Declaration>
        <Class IRI="naringenin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="findings"/>
    </Declaration>
    <Declaration>
        <Class IRI="death"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="oftendelay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="itstranscription"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="associationofchemotherapywithboost"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="randomdistribution"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="interventionfeasibility"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="detectiondiagnosis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±66"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="circumstances"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="associationwithboost"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="scavengingagainst"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="parameters"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="causeof"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wereassessedas"/>
    </Declaration>
    <Declaration>
        <Class IRI="pivotalroleofIRantagonistS961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="changesinbreastcosmesis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="werealsoassessedas"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="build"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="proposeddigitalphantom"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="functionalinformationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </Declaration>
    <Declaration>
        <Class IRI="penetrationpain"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ObjectiveBreastCosmesisScale"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="CXCL1expression"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="study2"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="markedlysuppressed"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="EgKI-1treatment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="time-enhancementcurves"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cancercells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="inmodel"/>
    </Declaration>
    <Declaration>
        <Class IRI="continuedpresenceofS961"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="showedgrowthto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highestgene"/>
    </Declaration>
    <Declaration>
        <Class IRI="only1patientofLevel1group"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="combinedtreatment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="example"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="increasingOPAEconcentrationupto240g/mL"/>
    </Declaration>
    <Declaration>
        <Class IRI="patients"/>
    </Declaration>
    <Declaration>
        <Class IRI="twogroupsincluding196patients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="therapyresistance"/>
    </Declaration>
    <Declaration>
        <Class IRI="lesstoxicity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERÎ±proteinlevels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="singletamoxifen"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="analysis"/>
    </Declaration>
    <Declaration>
        <Class IRI="pivotalroleofIRantagonistS961onIRsignalling"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highrecurrenceriskbeyond5yearsafterdiagnosis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="adjuvantbreastirradiation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Onephotograph"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcarcinomacells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="developmentofnewgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="weresignificantlydownregulatedin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="vary"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="understanding"/>
    </Declaration>
    <Declaration>
        <Class IRI="utilizationofacidforbreastcancertherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cancercellgrowth"/>
    </Declaration>
    <Declaration>
        <Class IRI="highCXCL1expression"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="developmentofgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="diagnosedwith"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="514womenwithbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isinducedby"/>
    </Declaration>
    <Declaration>
        <Class IRI="pivotalroleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="interstitialfractionatedhigh-dose-ratebrachytherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="humanbreast-cancercelllines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="HypofractionatedVMAT-SIB"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastCT."/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="resultsofotherstudiespublishedonassociationofhypofractionation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="modality"/>
    </Declaration>
    <Declaration>
        <Class IRI="EgKI-1-treatedmice"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="presenceofS961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Memorydecline"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breasttissueperfusion"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Ourdata"/>
    </Declaration>
    <Declaration>
        <Class IRI="T-PATappointment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Analysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="activityinmodels"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="furthervalidatedSOX4as"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="approximately3years"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="unclear"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrencesoccurring"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="voxel-basis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalaspectsofmalignantphenotypeincludingcellproliferation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tolerability"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosisofbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Â±standarddeviationSD"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalaspectsofphenotype"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="investigationinfuturestudies"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="differenttypesofbreastlesions"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="remains"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="phaseIItrial"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="blocked"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="anti-proliferativeeffectsof"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inhibits"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="patientswithhormonereceptor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="strategy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="anti-proliferativeeffectson"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="4Ddigitalbreastphantomincludingtime-varyingcontrastenhancementforsimulationofdedicatedbreastCTperfusionimaging"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Mostpatients"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="record"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancercells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="TAMs/CXCL1"/>
    </Declaration>
    <Declaration>
        <Class IRI="Breastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="areresponsiblefor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="OBCS"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="characteristics"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="IRantagonistS961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="therapies"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ERcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="novelutilizationof3-O-p-coumaroyltormenticacidforbreastcancertherapyviadisruption"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="healthypatientintoskinfibroglandulartissueadiposetissue"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="sexuality"/>
    </Declaration>
    <Declaration>
        <Class IRI="developmentoftumors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="furtherinvestigationinfuturestudies"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="regulator"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="evaluating"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aspectsofphenotypeincludingcellproliferation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasassociatedwith"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="welltoleratedin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancerpathogenesis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="roleofIRantagonistS961onIRsignalling"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrences"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="aim"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="intervention"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="women"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="receivedVMAT-SIBtechniquein"/>
    </Declaration>
    <Declaration>
        <Class IRI="cancer-relateddeath"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Ongoingresearch"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="arrested"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="expression"/>
    </Declaration>
    <Declaration>
        <Class IRI="developmentofnewgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="activity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breast-conservingsurgery"/>
    </Declaration>
    <Declaration>
        <Class IRI="oncosphereofcaninetapewormEchinococcus"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="5yearsofendocrinetherapyreduced"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="womenwithBCstreatedfrom2008to2017"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="estrogen-responsivegenes"/>
    </Declaration>
    <Declaration>
        <Class IRI="S961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="participants"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="supportivecare"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="addedto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellgrowthathigherconcentrations"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="15fractions"/>
    </Declaration>
    <Declaration>
        <Class IRI="HRpositivebreastcancerPI3Kinhibitors"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="arerequiredfor"/>
    </Declaration>
    <Declaration>
        <Class IRI="HRpositivemetastaticbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="nonstandardizedphotographs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="IR-Aisoform"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="EnrichmentAnalysis"/>
    </Declaration>
    <Declaration>
        <Class IRI="CXCL1administration"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="termsofacute"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="isolationofonecompound"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="selecting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="transcriptionalregulator"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalaspects"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="alsoinduced"/>
    </Declaration>
    <Declaration>
        <Class IRI="196patients"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="treatmentof"/>
    </Declaration>
    <Declaration>
        <Class IRI="humanepidermalgrowthfactorreceptor2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="correspondingtime-enhancementcurves"/>
    </Declaration>
    <Declaration>
        <Class IRI="functionalinformationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="combinatorialeffectson"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="realisticbeliefsaboutdiseasecurability"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="model"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="end"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="potentactivityinmodels"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrencesinpatients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="correspondingcurves"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="significantreduction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="G1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="assays"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="highrecurrenceriskbeyond5years"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancermetastasis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="benefit"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cancerprevention"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="association"/>
    </Declaration>
    <Declaration>
        <Class IRI="cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="51.1%ofpatientsG2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Level1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Level0"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="validatedSOX4as"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cells"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isnewparadigmfor"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="confirmed"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Level0doses"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="significantlyinhibited"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="presenting"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="isparadigmfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="nABregimen"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Taken"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="beaddedto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="early-stagebreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="initiationarelacking"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recombinantEgKI-1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="presence"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="majorityofare"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="disappeared"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="beforeandanotherwastakenfor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="laterecurrencerisk"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="multigeneassays"/>
    </Declaration>
    <Declaration>
        <Class IRI="antioxidantfree-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="indicate"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="furthervalidatedSOX4following"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="initiationofchemotherapytermsurvivaldataarelacking"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="blockedexpressionin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="typical4D"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="uniformdistribution"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="showspromiseas"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="CXCL1"/>
    </Declaration>
    <Declaration>
        <Class IRI="aldehydedehydrogenase"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Level1group"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="showedproliferationowingto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="perfusion"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Higherexpression"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="improves"/>
    </Declaration>
    <Declaration>
        <Class IRI="CXCL1expression"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="NF-ÎºB/SOX4activation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="anti-estrogentherapy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="regulating"/>
    </Declaration>
    <Declaration>
        <Class IRI="metastaticbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="improved"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="oncosphereoftapewormEchinococcus"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancerlymphnodemetastasis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasevaluatedby"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="patients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="benefitfromendocrinetherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="ET"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="show"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Grade3oralmucositis"/>
    </Declaration>
    <Declaration>
        <Class IRI="roleofIRantagonistS961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Patients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="recurrencerisk"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wereexposedto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="progressionsurvival"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Japanesepatientswithmetastaticbreastcancer"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="suppressing"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961onIRsignalling"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Howeverarestillrequiredfor"/>
    </Declaration>
    <Declaration>
        <Class IRI="breastcancermetastasis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="backboneof"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="objective"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="averageageofwas"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="disrupting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="laterecurrencesinpatientswithtumors"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="wasfoundFor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="progressionfreesurvival"/>
    </Declaration>
    <Declaration>
        <Class IRI="Femalepatients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="breastcancergrowth"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="weredividedinto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="anticanceractivities"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="terms"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Pearson&apos;scorrelationcoefficient"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="increasingOPAEconcentration"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="phytochemicals"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="evenpresenceofinsulin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="coactivators"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="efficacy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="weredownregulatedin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="severalaspectsofmalignantphenotype"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="loopTAMs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="roleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="blockedcellcyclein"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="interventioneasy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="dysfunctionalexcitement"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Cosmeticoutcomes"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="Furthermorearrested"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="cellapoptosis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="distribution"/>
    </Declaration>
    <Declaration>
        <Class IRI="penetrationpaindesirelubrication"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="estradiolhormone"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="informationofbreast"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="utilizationofacidforbreastcancertherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="tumorgrowthreductioninEgKI-1-treatedmice"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="excitement"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="lesstoxicity"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="inhibit"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="development"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="merit"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="death"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="15fractionsfortotaldose"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="mechanisms"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="significanttumorgrowthreductioninEgKI-1-treatedmice"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="pivotalroleonIRsignalling"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="tumormodels"/>
    </Declaration>
    <Declaration>
        <Class IRI="514womenwithbreastcancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="extendedendocrinetherapy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="iswith"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="associationofchemotherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="exponential"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="receivedVMAT-SIBtechniqueto"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="purpose"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="EgKI-1-treatedmice"/>
    </Declaration>
    <Declaration>
        <Class IRI="presenceofS961"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="growth"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="correlationcoefficient"/>
    </Declaration>
    <SubClassOf>
        <Class IRI="Breastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="CXCL1"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="CXCL1administration"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="CXCL1expression"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="CXCL1silencing"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="ERcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="EgKI-1-treatedmice"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="Femalepatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="GEM"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="HRpositivebreastcancerPI3Kinhibitors"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="HRpositivemetastaticbreastcancer"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="IRantagonistS961"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="Japanesepatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="Japanesepatientswithmetastaticbreastcancer"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="MTT"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="Mostpatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="Patientself-reports"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="S961"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="SOX4promoter"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="T-PATappointment"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="T-PATparticipants"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="advancedbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="advancedrecurrentbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="aldehydedehydrogenase"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="aldehydedehydrogenase"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="antioxidantfree-radicalscavengingagainsthumanbreast-cancercelllines"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancercellproliferation"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancercells"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancergrowth"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancerlymphnodemetastasis"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancermetastasis"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancerpathogenesis"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="breastcancerpatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="cancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="cancer-relateddeath"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="cancercellgrowth"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="cancercells"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="cancerprevention"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="co-treatmentoftamoxifen"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="continuedpresenceofS961"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="death"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="developmentofgenerationoftargetedtherapiesforadvancedbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="developmentofmammarytumors"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="developmentofnewgenerationoftargetedtherapiesforadvancedbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="developmentoftumors"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="early-stagebreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="endofRTtreatmentskintoxicity"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="estrogenreceptor"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="estrogenreceptor"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="evenpresenceofinsulin"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="free-radicalscavengingagainsthumanbreast-cancercelllines"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="functionalinformationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="growthpathwayinHRpositivebreastcancerPI3Kinhibitors"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="healthypatientintoskinfibroglandulartissueadiposetissue"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="highCXCL1expression"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="humanbreast-cancercelllines"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="humancelllines"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="humanepidermalgrowthfactorreceptor2"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="informationofbreastresultingindetectiondiagnosisofbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="informationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="laterecurrencesinpatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="laterecurrencesinpatientswithtumors"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="lesstoxicity"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="mTORinhibitoreverolimus"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="metastaticbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="mouse"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="naringenin"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="naringenintreatmentgroup"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="novelutilizationof3-O-p-coumaroyltormenticacidforbreastcancertherapyviadisruption"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="oncosphereofcaninetapewormEchinococcus"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="only1patientofLevel1group"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="otherpatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="participants"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="patient"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="patients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="patients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="patientselection"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="patientswithhormonereceptor"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="patientswithtumorsshowing"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="penetrationpain"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="penetrationpaindesirelubrication"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="percentcytotoxicity"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="pivotalroleofIRantagonistS961"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="pivotalroleofIRantagonistS961onIRsignalling"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="pivotalroleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="plasmaIL-6levels"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="presenceofS961"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="progressionofbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="recurrencesinpatients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="recurrencesinpatientswithtumors"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="reductioninbreastcancergrowth"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="roleofIRantagonistS961"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="roleofIRantagonistS961onIRsignalling"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="roleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="selectiveestrogenreceptormodulators"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="selectiveestrogenreceptormodulators"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="significantreductioninbreastcancergrowth"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="significanttumorgrowthreduction"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="significanttumorgrowthreduction"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="significanttumorgrowthreductioninEgKI-1-treatedmice"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="singletamoxifen"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="tamoxifen"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="treatmentofadvancedHRpositiveHER2negativebreastcancerhighlighting"/>
        <Class IRI="Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="tumorgrowthreduction"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="tumorgrowthreductioninEgKI-1-treatedmice"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="tumorgrowthreductioninmice"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="tumormodels"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="tumorsshowing"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="twogroupsincluding196patients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="utilizationforbreastcancertherapyviadisruption"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="utilizationofacidforbreastcancertherapy"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="women"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="women"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="womenwithBCstreatedfrom2008to2017"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="womenwithHER2-positiveBCstreatedwithtrastuzumab"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="womenwithHER2-positiveBCstreatedwithtrastuzumabfrom2008to2017"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="womenwithbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="196patients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="3patients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="4patients"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="5yearsoftamoxifentherapywith5yearsoftamoxifen"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="51.1%ofpatientsG2"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="514women"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="514women"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="514womenwithbreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="ER-positive/humanepidermalgrowthfactorreceptor2-negativebreastcancer"/>
        <Class IRI="Disease"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="ERÎ±polyubiquitinationestrogenreceptordegraders"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="ERÎ±polyubiquitinationselectiveestrogenreceptordegraders"/>
        <Class IRI="Chemical"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="Women&apos;sSexualFunction"/>
        <Class IRI="Species"/>
    </SubClassOf>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="Breastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="CXCL1"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="CXCL1administration"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="CXCL1expression"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="CXCL1silencing"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="ERcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="EgKI-1-treatedmice"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="Femalepatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="GEM"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="HRpositivebreastcancerPI3Kinhibitors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="HRpositivemetastaticbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="IRantagonistS961"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="Japanesepatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="Japanesepatientswithmetastaticbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="MTT"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="Mostpatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="Patientself-reports"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="S961"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="SOX4promoter"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="T-PATappointment"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="T-PATparticipants"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="advancedbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="advancedrecurrentbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="aldehydedehydrogenase"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="aldehydedehydrogenase"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="antioxidantfree-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancercellproliferation"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancercells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancergrowth"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancerlymphnodemetastasis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancermetastasis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="breastcancerpathogenesis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="breastcancerpatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="cancer-relateddeath"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="cancercellgrowth"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="cancercells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="cancerprevention"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="co-treatmentoftamoxifen"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="continuedpresenceofS961"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="death"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="developmentofgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="developmentofmammarytumors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="developmentofnewgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="developmentoftumors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="early-stagebreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="endofRTtreatmentskintoxicity"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="estrogenreceptor"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="estrogenreceptor"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="evenpresenceofinsulin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="free-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="functionalinformationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="growthpathwayinHRpositivebreastcancerPI3Kinhibitors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="healthypatientintoskinfibroglandulartissueadiposetissue"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="highCXCL1expression"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="humanbreast-cancercelllines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="humancelllines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="humanepidermalgrowthfactorreceptor2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosisofbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="laterecurrencesinpatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="laterecurrencesinpatientswithtumors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="lesstoxicity"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="metastaticbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="mouse"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="naringenin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="naringenintreatmentgroup"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="novelutilizationof3-O-p-coumaroyltormenticacidforbreastcancertherapyviadisruption"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="oncosphereofcaninetapewormEchinococcus"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="only1patientofLevel1group"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="otherpatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="participants"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="patient"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="patientselection"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="patientswithhormonereceptor"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="patientswithtumorsshowing"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="penetrationpain"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="penetrationpaindesirelubrication"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961onIRsignalling"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="plasmaIL-6levels"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="presenceofS961"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="progressionofbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="recurrencesinpatients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="recurrencesinpatientswithtumors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="reductioninbreastcancergrowth"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="roleofIRantagonistS961"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="roleofIRantagonistS961onIRsignalling"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="roleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="selectiveestrogenreceptormodulators"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="selectiveestrogenreceptormodulators"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="significantreductioninbreastcancergrowth"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="significanttumorgrowthreduction"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="significanttumorgrowthreduction"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="significanttumorgrowthreductioninEgKI-1-treatedmice"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="singletamoxifen"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="tamoxifen"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Gene"/>
        <NamedIndividual IRI="treatmentofadvancedHRpositiveHER2negativebreastcancerhighlighting"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="tumorgrowthreduction"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="tumorgrowthreductioninEgKI-1-treatedmice"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="tumorgrowthreductioninmice"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="tumormodels"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="tumorsshowing"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="twogroupsincluding196patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="utilizationforbreastcancertherapyviadisruption"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="utilizationofacidforbreastcancertherapy"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="women"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="women"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="womenwithBCstreatedfrom2008to2017"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="womenwithHER2-positiveBCstreatedwithtrastuzumab"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="womenwithHER2-positiveBCstreatedwithtrastuzumabfrom2008to2017"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="womenwithbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="196patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="3patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="4patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="5yearsoftamoxifentherapywith5yearsoftamoxifen"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="51.1%ofpatientsG2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="514women"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="514women"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="514womenwithbreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Disease"/>
        <NamedIndividual IRI="ER-positive/humanepidermalgrowthfactorreceptor2-negativebreastcancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="ERÎ±polyubiquitinationestrogenreceptordegraders"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Chemical"/>
        <NamedIndividual IRI="ERÎ±polyubiquitinationselectiveestrogenreceptordegraders"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="Species"/>
        <NamedIndividual IRI="Women&apos;sSexualFunction"/>
    </ClassAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="washighbetween"/>
        <NamedIndividual IRI="Agreement"/>
        <NamedIndividual IRI="trainees"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hasledto"/>
        <NamedIndividual IRI="Analysis"/>
        <NamedIndividual IRI="developmentofgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hasledto"/>
        <NamedIndividual IRI="Analysis"/>
        <NamedIndividual IRI="developmentofnewgenerationoftargetedtherapiesforadvancedbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="causeof"/>
        <NamedIndividual IRI="Breastcancer"/>
        <NamedIndividual IRI="cancer-relateddeath"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="second-leadingcauseof"/>
        <NamedIndividual IRI="Breastcancer"/>
        <NamedIndividual IRI="death"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="activates"/>
        <NamedIndividual IRI="CXCL1"/>
        <NamedIndividual IRI="itstranscription"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="bindsto"/>
        <NamedIndividual IRI="CXCL1"/>
        <NamedIndividual IRI="SOX4promoter"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iscorrelatedwith"/>
        <NamedIndividual IRI="CXCL1expression"/>
        <NamedIndividual IRI="breastcancerlymphnodemetastasis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="issignificantlycorrelatedwith"/>
        <NamedIndividual IRI="CXCL1expression"/>
        <NamedIndividual IRI="breastcancerlymphnodemetastasis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="CXCL1silencing"/>
        <NamedIndividual IRI="TAMs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultsin"/>
        <NamedIndividual IRI="CXCL1silencing"/>
        <NamedIndividual IRI="reduction"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultsin"/>
        <NamedIndividual IRI="CXCL1silencing"/>
        <NamedIndividual IRI="reductioninbreastcancergrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultsin"/>
        <NamedIndividual IRI="CXCL1silencing"/>
        <NamedIndividual IRI="significantreductioninbreastcancergrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="werealsoassessedas"/>
        <NamedIndividual IRI="Cosmeticoutcomes"/>
        <NamedIndividual IRI="excellent/good"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wereassessedas"/>
        <NamedIndividual IRI="Cosmeticoutcomes"/>
        <NamedIndividual IRI="excellent/good"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ofdosesis"/>
        <NamedIndividual IRI="ERI"/>
        <NamedIndividual IRI="Level0"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="affecting"/>
        <NamedIndividual IRI="EgKI-1"/>
        <NamedIndividual IRI="normalcellgrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibitsmigrationin"/>
        <NamedIndividual IRI="EgKI-1"/>
        <NamedIndividual IRI="dose-dependentmanner"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="shows"/>
        <NamedIndividual IRI="EgKI-1"/>
        <NamedIndividual IRI="promiseforfuturedevelopment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showspromiseas"/>
        <NamedIndividual IRI="EgKI-1"/>
        <NamedIndividual IRI="anti-cancertherapeutic"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Furthermorearrested"/>
        <NamedIndividual IRI="EgKI-1treatment"/>
        <NamedIndividual IRI="cancercellgrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arrested"/>
        <NamedIndividual IRI="EgKI-1treatment"/>
        <NamedIndividual IRI="cancercellgrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="disrupting"/>
        <NamedIndividual IRI="EgKI-1treatment"/>
        <NamedIndividual IRI="cellcycle"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldoptimize"/>
        <NamedIndividual IRI="Enhancedunderstanding"/>
        <NamedIndividual IRI="patientselection"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldoptimizepatientselectionin"/>
        <NamedIndividual IRI="Enhancedunderstanding"/>
        <NamedIndividual IRI="setting"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasappliedon"/>
        <NamedIndividual IRI="EnrichmentAnalysis"/>
        <NamedIndividual IRI="genes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canreduce"/>
        <NamedIndividual IRI="Extendedendocrinetherapy"/>
        <NamedIndividual IRI="recurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canreduce"/>
        <NamedIndividual IRI="Extendedendocrinetherapy"/>
        <NamedIndividual IRI="recurrencesoccurring"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canreduce"/>
        <NamedIndividual IRI="Extendedtherapy"/>
        <NamedIndividual IRI="recurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canreduce"/>
        <NamedIndividual IRI="Extendedtherapy"/>
        <NamedIndividual IRI="recurrencesoccurring"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="diagnosedwith"/>
        <NamedIndividual IRI="Femalepatients"/>
        <NamedIndividual IRI="advancedbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasAt"/>
        <NamedIndividual IRI="G1"/>
        <NamedIndividual IRI="end"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasAt"/>
        <NamedIndividual IRI="G1"/>
        <NamedIndividual IRI="endofRTtreatmentskintoxicity"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasin"/>
        <NamedIndividual IRI="G1"/>
        <NamedIndividual IRI="51.1%ofpatientsG2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="Higherexpression"/>
        <NamedIndividual IRI="highrecurrencerisk"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="Higherexpression"/>
        <NamedIndividual IRI="highrecurrenceriskbeyond5years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="Higherexpression"/>
        <NamedIndividual IRI="highrecurrenceriskbeyond5yearsafterdiagnosis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="Higherexpression"/>
        <NamedIndividual IRI="recurrencerisk"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="Higherexpression"/>
        <NamedIndividual IRI="recurrenceriskbeyond5years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="Higherexpression"/>
        <NamedIndividual IRI="recurrenceriskbeyond5yearsafterdiagnosis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="HypofractionatedVMAT-SIB"/>
        <NamedIndividual IRI="patients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="toleratedin"/>
        <NamedIndividual IRI="HypofractionatedVMAT-SIB"/>
        <NamedIndividual IRI="termsofacute"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="welltoleratedin"/>
        <NamedIndividual IRI="HypofractionatedVMAT-SIB"/>
        <NamedIndividual IRI="terms"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="welltoleratedin"/>
        <NamedIndividual IRI="HypofractionatedVMAT-SIB"/>
        <NamedIndividual IRI="termsofacute"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="IRantagonistS961"/>
        <NamedIndividual IRI="antagonism"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="IRantagonistS961"/>
        <NamedIndividual IRI="distinctantagonism"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weredownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="continuedpresence"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weredownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="continuedpresenceofS961"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weredownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="presenceofS961"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weresignificantlydownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="continuedpresence"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weresignificantlydownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="continuedpresenceofS961"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weresignificantlydownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="presence"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weresignificantlydownregulatedin"/>
        <NamedIndividual IRI="IRmRNAexpressionlevels"/>
        <NamedIndividual IRI="presenceofS961"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="IRsignalling"/>
        <NamedIndividual IRI="MCF-7MDA-MB-231"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="Iclinicalstudy"/>
        <NamedIndividual IRI="Japanesepatientswithmetastaticbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="washigherin"/>
        <NamedIndividual IRI="ImmediateVerbalMemoryIndex"/>
        <NamedIndividual IRI="study2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wassignificantlyhigherin"/>
        <NamedIndividual IRI="ImmediateVerbalMemoryIndex"/>
        <NamedIndividual IRI="study2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialapplications"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialapplications"/>
        <NamedIndividual IRI="furtherinvestigationinfuturestudies"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialapplications"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialpracticalapplications"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialpracticalapplications"/>
        <NamedIndividual IRI="furtherinvestigationinfuturestudies"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialpracticalapplications"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="merit"/>
        <NamedIndividual IRI="Itspotentialpracticalapplications"/>
        <NamedIndividual IRI="investigationinfuturestudies"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="Japanesepatients"/>
        <NamedIndividual IRI="metastaticbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ofpatientis"/>
        <NamedIndividual IRI="Level1group"/>
        <NamedIndividual IRI="Grade3oralmucositis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="pathway"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="laterecurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="laterecurrencesinpatients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="laterecurrencesinpatientswithtumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="recurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="recurrencesinpatients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="Long-termintervention"/>
        <NamedIndividual IRI="recurrencesinpatientswithtumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="Memorydecline"/>
        <NamedIndividual IRI="breastcancerpatients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="found"/>
        <NamedIndividual IRI="Mostpatients"/>
        <NamedIndividual IRI="T-PATappointment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="found"/>
        <NamedIndividual IRI="Mostpatients"/>
        <NamedIndividual IRI="appointment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="beforeandanotherwastakenfor"/>
        <NamedIndividual IRI="Onephotograph"/>
        <NamedIndividual IRI="patient"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="beforewastakenfor"/>
        <NamedIndividual IRI="Onephotograph"/>
        <NamedIndividual IRI="patient"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="record"/>
        <NamedIndividual IRI="Onephotograph"/>
        <NamedIndividual IRI="changes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="record"/>
        <NamedIndividual IRI="Onephotograph"/>
        <NamedIndividual IRI="changesinbreastcosmesis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluating"/>
        <NamedIndividual IRI="Ongoingresearch"/>
        <NamedIndividual IRI="mechanisms"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluating"/>
        <NamedIndividual IRI="Ongoingresearch"/>
        <NamedIndividual IRI="potentialbiomarkers"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluating"/>
        <NamedIndividual IRI="Ongoingresearch"/>
        <NamedIndividual IRI="potentialbiomarkersofresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isanticipated"/>
        <NamedIndividual IRI="Ongoingresearch"/>
        <NamedIndividual IRI="continue"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
        <NamedIndividual IRI="activity"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
        <NamedIndividual IRI="activityinin-vitromodels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
        <NamedIndividual IRI="activityinmodels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
        <NamedIndividual IRI="potentactivity"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
        <NamedIndividual IRI="potentactivityinin-vitromodels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="Orthosiphonpallidusextract"/>
        <NamedIndividual IRI="potentactivityinmodels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="confirmed"/>
        <NamedIndividual IRI="Ourdata"/>
        <NamedIndividual IRI="resultsofotherstudiespublishedonassociationofhypofractionation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="presenting"/>
        <NamedIndividual IRI="Patients"/>
        <NamedIndividual IRI="breastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="presenting"/>
        <NamedIndividual IRI="Patients"/>
        <NamedIndividual IRI="early-stagebreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wereenrolledin"/>
        <NamedIndividual IRI="Patients"/>
        <NamedIndividual IRI="phaseIItrial"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="werecomparedacross"/>
        <NamedIndividual IRI="Patientself-reports"/>
        <NamedIndividual IRI="intervention"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="furthervalidatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="gene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="furthervalidatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="highestgene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="furthervalidatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="highestresponsivegene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="furthervalidatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="responsivegene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="furthervalidatedSOX4following"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="CXCL1administration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="validatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="highestgene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="validatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="highestresponsivegene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="validatedSOX4as"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="responsivegene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="validatedSOX4following"/>
        <NamedIndividual IRI="QPCRscreening"/>
        <NamedIndividual IRI="CXCL1administration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="show"/>
        <NamedIndividual IRI="Results"/>
        <NamedIndividual IRI="expectedenhancementoftissuesconsistentwithgiveninputparameters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="alsoinhibited"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="cellularproliferationinbreasttumourcells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="blocked"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="expressionofIRs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="blockedexpressionin"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="evenpresenceofinsulin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="downregulated"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="IRs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="downregulatedIRswith"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="nanomolardose"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="efficientlyblocked"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="expressionofIRs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibited"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="cellularproliferationinbreasttumourcells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibited"/>
        <NamedIndividual IRI="S961"/>
        <NamedIndividual IRI="proliferationinbreasttumourcells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="waschangedin"/>
        <NamedIndividual IRI="Sexualfunction"/>
        <NamedIndividual IRI="women"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="waschangedin"/>
        <NamedIndividual IRI="Sexualfunction"/>
        <NamedIndividual IRI="womenwithbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hold"/>
        <NamedIndividual IRI="T-PATparticipants"/>
        <NamedIndividual IRI="realisticbeliefsaboutdiseasecurability"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isnewparadigmfor"/>
        <NamedIndividual IRI="TargetingbreastCSCs"/>
        <NamedIndividual IRI="cancerprevention"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isparadigmfor"/>
        <NamedIndividual IRI="TargetingbreastCSCs"/>
        <NamedIndividual IRI="cancerprevention"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="TargetingbreastCSCs"/>
        <NamedIndividual IRI="phytochemicals"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="washigherin"/>
        <NamedIndividual IRI="TheDelayed"/>
        <NamedIndividual IRI="study2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wassignificantlyhigherin"/>
        <NamedIndividual IRI="TheDelayed"/>
        <NamedIndividual IRI="study2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wererecordedon"/>
        <NamedIndividual IRI="Theirtreatment-relatedcosmeticchanges"/>
        <NamedIndividual IRI="nonstandardizedphotographs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="toleratedin"/>
        <NamedIndividual IRI="VMAT-SIB"/>
        <NamedIndividual IRI="termsofacute"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="using"/>
        <NamedIndividual IRI="acceleratedpartialbreastirradiation"/>
        <NamedIndividual IRI="brachytherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="antioxidantfree-radicalscavengingagainst"/>
        <NamedIndividual IRI="activities"/>
        <NamedIndividual IRI="celllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="antioxidantfree-radicalscavengingagainst"/>
        <NamedIndividual IRI="activities"/>
        <NamedIndividual IRI="humanbreast-cancercelllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="antioxidantfree-radicalscavengingagainst"/>
        <NamedIndividual IRI="activities"/>
        <NamedIndividual IRI="humancelllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isrelatedto"/>
        <NamedIndividual IRI="activity"/>
        <NamedIndividual IRI="endocrinetherapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="adjuvantbreastradiotherapy"/>
        <NamedIndividual IRI="breastconservationtherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remainsfor"/>
        <NamedIndividual IRI="agents"/>
        <NamedIndividual IRI="idealstrategy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="assess"/>
        <NamedIndividual IRI="aim"/>
        <NamedIndividual IRI="OBCS"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="assess"/>
        <NamedIndividual IRI="aim"/>
        <NamedIndividual IRI="ObjectiveBreastCosmesisScale"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressing"/>
        <NamedIndividual IRI="aldehydedehydrogenase"/>
        <NamedIndividual IRI="expressionofself-renewal-relatedgenes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="assess"/>
        <NamedIndividual IRI="analysis"/>
        <NamedIndividual IRI="interventionfeasibility"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="anthracycline-basedadjuvanttherapies"/>
        <NamedIndividual IRI="humanepidermalgrowthfactorreceptor2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="anti-estrogentherapy"/>
        <NamedIndividual IRI="selectiveestrogenreceptormodulators"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="antioxidantfree-radicalscavengingagainst"/>
        <NamedIndividual IRI="anticanceractivities"/>
        <NamedIndividual IRI="humanbreast-cancercelllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="scavengingagainst"/>
        <NamedIndividual IRI="anticanceractivities"/>
        <NamedIndividual IRI="humancelllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="aqueousOrthosiphonpallidusextract"/>
        <NamedIndividual IRI="potentactivityinin-vitromodels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="supplying"/>
        <NamedIndividual IRI="arterialsources"/>
        <NamedIndividual IRI="breast"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressionin"/>
        <NamedIndividual IRI="aspects"/>
        <NamedIndividual IRI="breastcancerpathogenesis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="upregulatedexpressionof"/>
        <NamedIndividual IRI="aspects"/>
        <NamedIndividual IRI="IRs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="assays"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="assays"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="using"/>
        <NamedIndividual IRI="association"/>
        <NamedIndividual IRI="Pearson&apos;scorrelationcoefficient"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="sufferingfrom"/>
        <NamedIndividual IRI="averagetime"/>
        <NamedIndividual IRI="cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressed"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="IR-Aisoform"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predominantlyexpressed"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="IR-Aisoform"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="extensivegrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="growth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="proliferationowing"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showedgrowthto"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="IRoverexpression"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showedproliferationowingto"/>
        <NamedIndividual IRI="breastcancercells"/>
        <NamedIndividual IRI="IRoverexpression"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="beaddedto"/>
        <NamedIndividual IRI="breastlesionmodel"/>
        <NamedIndividual IRI="phantom"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="soonwasrestoredafter"/>
        <NamedIndividual IRI="breastradiotherapy"/>
        <NamedIndividual IRI="approximately3years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasrestoredafter"/>
        <NamedIndividual IRI="breastradiotherapy"/>
        <NamedIndividual IRI="approximately3years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="apoptosisof"/>
        <NamedIndividual IRI="cellcycle"/>
        <NamedIndividual IRI="cancercells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="combinedtreatmentof"/>
        <NamedIndividual IRI="cellcycle"/>
        <NamedIndividual IRI="tamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inducedapoptosisof"/>
        <NamedIndividual IRI="cellcycle"/>
        <NamedIndividual IRI="cancercells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="treatmentof"/>
        <NamedIndividual IRI="cellcycle"/>
        <NamedIndividual IRI="tamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibitedcellproliferationin"/>
        <NamedIndividual IRI="cellgrowth"/>
        <NamedIndividual IRI="additivemanner"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="significantlyinhibited"/>
        <NamedIndividual IRI="cellgrowth"/>
        <NamedIndividual IRI="cellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="combinedtreatmentof"/>
        <NamedIndividual IRI="cellmigration"/>
        <NamedIndividual IRI="tamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Taken"/>
        <NamedIndividual IRI="cellproliferation"/>
        <NamedIndividual IRI="co-treatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Taken"/>
        <NamedIndividual IRI="cellproliferation"/>
        <NamedIndividual IRI="co-treatmentoftamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Takentogether"/>
        <NamedIndividual IRI="cellproliferation"/>
        <NamedIndividual IRI="co-treatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Takentogether"/>
        <NamedIndividual IRI="cellproliferation"/>
        <NamedIndividual IRI="co-treatmentoftamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wereexposedto"/>
        <NamedIndividual IRI="cells"/>
        <NamedIndividual IRI="singletamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="changes"/>
        <NamedIndividual IRI="WMS-Rindicesbetweentwostudies"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="changes"/>
        <NamedIndividual IRI="breastcosmesis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="changes"/>
        <NamedIndividual IRI="plasmaIL-6levels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="changes"/>
        <NamedIndividual IRI="sexuality"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluate"/>
        <NamedIndividual IRI="characteristics"/>
        <NamedIndividual IRI="perfusionindifferenttypesofbreastlesions"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="chromatographicpreparations"/>
        <NamedIndividual IRI="isolation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="chromatographicpreparations"/>
        <NamedIndividual IRI="isolationofonecompound"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="influencefunctionwith"/>
        <NamedIndividual IRI="circumstances"/>
        <NamedIndividual IRI="breastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="build"/>
        <NamedIndividual IRI="clinicians"/>
        <NamedIndividual IRI="prognosisdiscussioncommunicationskills"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="found"/>
        <NamedIndividual IRI="clinicians"/>
        <NamedIndividual IRI="interventioneasy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="clinicopathologicalparameters"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="clinicopathologicalparameters"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="alsoinduced"/>
        <NamedIndividual IRI="co-treatment"/>
        <NamedIndividual IRI="cellapoptosis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulating"/>
        <NamedIndividual IRI="co-treatment"/>
        <NamedIndividual IRI="expressionofmitochondrialapoptoticproteins"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="combinationtherapy"/>
        <NamedIndividual IRI="ERI"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="blocked"/>
        <NamedIndividual IRI="combinedtreatment"/>
        <NamedIndividual IRI="cellcycle"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="blockedcellcyclein"/>
        <NamedIndividual IRI="combinedtreatment"/>
        <NamedIndividual IRI="G2/Mphase"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="markedlysuppressed"/>
        <NamedIndividual IRI="combinedtreatment"/>
        <NamedIndividual IRI="cellmigration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="suppressed"/>
        <NamedIndividual IRI="combinedtreatment"/>
        <NamedIndividual IRI="cellmigration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="suppressing"/>
        <NamedIndividual IRI="combinedtreatment"/>
        <NamedIndividual IRI="transcription"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="suppressing"/>
        <NamedIndividual IRI="combinedtreatment"/>
        <NamedIndividual IRI="transcriptionofcellcycleregulationproteins"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibits"/>
        <NamedIndividual IRI="compound"/>
        <NamedIndividual IRI="breastcancercellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibitsbreastcancercellproliferationin"/>
        <NamedIndividual IRI="compound"/>
        <NamedIndividual IRI="dose-dependentmanner"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="reduces"/>
        <NamedIndividual IRI="compound"/>
        <NamedIndividual IRI="ALDH"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="reduces"/>
        <NamedIndividual IRI="compound"/>
        <NamedIndividual IRI="aldehydedehydrogenase"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="reduces"/>
        <NamedIndividual IRI="compound"/>
        <NamedIndividual IRI="CD44high/CD24lowsubpopulation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="rangedbefore"/>
        <NamedIndividual IRI="correlationcoefficient"/>
        <NamedIndividual IRI="treatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arecomputedfor"/>
        <NamedIndividual IRI="correspondingcurves"/>
        <NamedIndividual IRI="voxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arecomputedfor"/>
        <NamedIndividual IRI="correspondingtime-enhancementcurves"/>
        <NamedIndividual IRI="voxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="review"/>
        <NamedIndividual IRI="cosmeticoutcomes"/>
        <NamedIndividual IRI="associationofchemotherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="review"/>
        <NamedIndividual IRI="cosmeticoutcomes"/>
        <NamedIndividual IRI="associationofchemotherapywithboost"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="review"/>
        <NamedIndividual IRI="cosmeticoutcomes"/>
        <NamedIndividual IRI="associationwithboost"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arecalculatedby"/>
        <NamedIndividual IRI="curves"/>
        <NamedIndividual IRI="convolutionbetweenarterialinputfunction"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arecomputedfor"/>
        <NamedIndividual IRI="curves"/>
        <NamedIndividual IRI="voxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Thereforeselecting"/>
        <NamedIndividual IRI="damage"/>
        <NamedIndividual IRI="nABregimen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="selecting"/>
        <NamedIndividual IRI="damage"/>
        <NamedIndividual IRI="nABregimen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remains"/>
        <NamedIndividual IRI="data"/>
        <NamedIndividual IRI="unclear"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remainsfor"/>
        <NamedIndividual IRI="data"/>
        <NamedIndividual IRI="idealstrategy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remainsfor"/>
        <NamedIndividual IRI="data"/>
        <NamedIndividual IRI="sequencing"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remainsfor"/>
        <NamedIndividual IRI="data"/>
        <NamedIndividual IRI="strategy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="majorityofare"/>
        <NamedIndividual IRI="deaths"/>
        <NamedIndividual IRI="patientswithhormonereceptor"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="detectiondiagnosis"/>
        <NamedIndividual IRI="breastCT."/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="diagnosis"/>
        <NamedIndividual IRI="estrogenreceptor"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canmodel"/>
        <NamedIndividual IRI="digitalphantom"/>
        <NamedIndividual IRI="breasttissueperfusion"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isused"/>
        <NamedIndividual IRI="distribution"/>
        <NamedIndividual IRI="vary"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isused"/>
        <NamedIndividual IRI="distribution"/>
        <NamedIndividual IRI="varyonvoxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="vary"/>
        <NamedIndividual IRI="distribution"/>
        <NamedIndividual IRI="perfusionparameters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="varyon"/>
        <NamedIndividual IRI="distribution"/>
        <NamedIndividual IRI="voxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="varyperfusionparameterson"/>
        <NamedIndividual IRI="distribution"/>
        <NamedIndividual IRI="voxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasfoundin"/>
        <NamedIndividual IRI="dose"/>
        <NamedIndividual IRI="Grade3oralmucositis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasfoundin"/>
        <NamedIndividual IRI="dose"/>
        <NamedIndividual IRI="only1patientofLevel1group"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wereescalatedfor"/>
        <NamedIndividual IRI="doses"/>
        <NamedIndividual IRI="GEM"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wereescalatedfor"/>
        <NamedIndividual IRI="doses"/>
        <NamedIndividual IRI="Level1"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weredueto"/>
        <NamedIndividual IRI="dysfunctions"/>
        <NamedIndividual IRI="penetrationpain"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="disappeared"/>
        <NamedIndividual IRI="effect"/>
        <NamedIndividual IRI="5yearsofendocrinetherapyreduced"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="disappearedafter"/>
        <NamedIndividual IRI="effect"/>
        <NamedIndividual IRI="treatmentcessation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasevaluatedby"/>
        <NamedIndividual IRI="effect"/>
        <NamedIndividual IRI="MTT"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="feasibilityof"/>
        <NamedIndividual IRI="effects"/>
        <NamedIndividual IRI="plannedprognosisdiscussion"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="efficacy"/>
        <NamedIndividual IRI="combinationwithotherchemotherapeuticagents"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="epithelial-mesenchymaltransition"/>
        <NamedIndividual IRI="mouse"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="indiagnosisis"/>
        <NamedIndividual IRI="estrogenreceptor"/>
        <NamedIndividual IRI="laterecurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areresponsiblefor"/>
        <NamedIndividual IRI="events"/>
        <NamedIndividual IRI="increaseinERÎ±proteinlevels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="dependson"/>
        <NamedIndividual IRI="exponential"/>
        <NamedIndividual IRI="perfusionparametersassociatedwithtissuevoxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="aspectsofmalignantphenotype"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="aspectsofmalignantphenotypeincludingcellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="aspectsofphenotypeincludingcellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="severalaspects"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="severalaspectsofmalignantphenotype"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="severalaspectsofmalignantphenotypeincludingcellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="severalaspectsofphenotype"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="severalaspectsofphenotypeincludingcellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="highrecurrencerisk"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="highrecurrenceriskbeyond5years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="highrecurrenceriskbeyond5yearsafterdiagnosis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="recurrencerisk"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="recurrenceriskbeyond5years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasassociatedwith"/>
        <NamedIndividual IRI="expression"/>
        <NamedIndividual IRI="recurrenceriskbeyond5yearsafterdiagnosis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isrelatedto"/>
        <NamedIndividual IRI="extranuclearactivity"/>
        <NamedIndividual IRI="endocrinetherapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isrelatedto"/>
        <NamedIndividual IRI="extranuclearactivity"/>
        <NamedIndividual IRI="therapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="indicate"/>
        <NamedIndividual IRI="findings"/>
        <NamedIndividual IRI="novelutilizationof3-O-p-coumaroyltormenticacidforbreastcancertherapyviadisruption"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="indicate"/>
        <NamedIndividual IRI="findings"/>
        <NamedIndividual IRI="utilizationforbreastcancertherapyviadisruption"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="indicate"/>
        <NamedIndividual IRI="findings"/>
        <NamedIndividual IRI="utilizationofacidforbreastcancertherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="furtherinvestigation"/>
        <NamedIndividual IRI="futurestudies"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iscorrelatedwith"/>
        <NamedIndividual IRI="highCXCL1expression"/>
        <NamedIndividual IRI="breastcancerlymphnodemetastasis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="issignificantlycorrelatedwith"/>
        <NamedIndividual IRI="highCXCL1expression"/>
        <NamedIndividual IRI="breastcancerlymphnodemetastasis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="importantgrowthpathway"/>
        <NamedIndividual IRI="HRpositivebreastcancerPI3Kinhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="increase"/>
        <NamedIndividual IRI="ERÎ±proteinlevels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="inmodel"/>
        <NamedIndividual IRI="tumorgrowthreduction"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="werequestionnaireon"/>
        <NamedIndividual IRI="instruments"/>
        <NamedIndividual IRI="Women&apos;sSexualFunction"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="intervention"/>
        <NamedIndividual IRI="laterecurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="intervention"/>
        <NamedIndividual IRI="laterecurrencesinpatients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="intervention"/>
        <NamedIndividual IRI="laterecurrencesinpatientswithtumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="intervention"/>
        <NamedIndividual IRI="recurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="intervention"/>
        <NamedIndividual IRI="recurrencesinpatients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="mightreduce"/>
        <NamedIndividual IRI="intervention"/>
        <NamedIndividual IRI="recurrencesinpatientswithtumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="rangedbefore"/>
        <NamedIndividual IRI="intraclasscorrelationcoefficient"/>
        <NamedIndividual IRI="treatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="anti-proliferativeeffectsof"/>
        <NamedIndividual IRI="investigated"/>
        <NamedIndividual IRI="tamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="anti-proliferativeeffectson"/>
        <NamedIndividual IRI="investigated"/>
        <NamedIndividual IRI="ERcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="combinatorialanti-proliferativeeffectson"/>
        <NamedIndividual IRI="investigated"/>
        <NamedIndividual IRI="ERcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="combinatorialeffectson"/>
        <NamedIndividual IRI="investigated"/>
        <NamedIndividual IRI="ERcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="effectson"/>
        <NamedIndividual IRI="investigated"/>
        <NamedIndividual IRI="ERcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Extending"/>
        <NamedIndividual IRI="laterecurrencerisk"/>
        <NamedIndividual IRI="5yearsoftamoxifentherapywith5yearsoftamoxifen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="laterecurrences"/>
        <NamedIndividual IRI="patientswithtumorsshowing"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="laterecurrences"/>
        <NamedIndividual IRI="highexpressionofestrogen-responsivegenes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predicting"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
        <NamedIndividual IRI="benefit"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predicting"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
        <NamedIndividual IRI="benefitfromendocrinetherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predicting"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
        <NamedIndividual IRI="benefitfromextendedendocrinetherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="using"/>
        <NamedIndividual IRI="mRNAexpression"/>
        <NamedIndividual IRI="quantitativePCR"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasmeasuredin"/>
        <NamedIndividual IRI="mRNAexpression"/>
        <NamedIndividual IRI="breastcarcinomacells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="addedto"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="ET"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="improved"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="supportivecare"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="improved"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="supportivecareallowing"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="improves"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="progressionfreesurvival"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="improves"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="progressionsurvival"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="significantlyimproves"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="progressionfreesurvival"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="significantlyimproves"/>
        <NamedIndividual IRI="mTORinhibitoreverolimus"/>
        <NamedIndividual IRI="progressionsurvival"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="mainproblems"/>
        <NamedIndividual IRI="dysfunctionalexcitement"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="mainproblems"/>
        <NamedIndividual IRI="excitement"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="mainproblems"/>
        <NamedIndividual IRI="penetrationpaindesirelubrication"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arein"/>
        <NamedIndividual IRI="majority"/>
        <NamedIndividual IRI="patients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arein"/>
        <NamedIndividual IRI="majority"/>
        <NamedIndividual IRI="patientswithhormonereceptor"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="managementchallenges"/>
        <NamedIndividual IRI="treatmentofadvancedHRpositiveHER2negativebreastcancerhighlighting"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="maykeyfactor"/>
        <NamedIndividual IRI="progressionofbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remains"/>
        <NamedIndividual IRI="mechanisms"/>
        <NamedIndividual IRI="unclear"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="underlying"/>
        <NamedIndividual IRI="mechanisms"/>
        <NamedIndividual IRI="cognitivedecline"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="underlying"/>
        <NamedIndividual IRI="mechanisms"/>
        <NamedIndividual IRI="decline"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isexpressedby"/>
        <NamedIndividual IRI="member"/>
        <NamedIndividual IRI="oncosphere"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isexpressedby"/>
        <NamedIndividual IRI="member"/>
        <NamedIndividual IRI="oncosphereofcaninetapewormEchinococcus"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isexpressedby"/>
        <NamedIndividual IRI="member"/>
        <NamedIndividual IRI="oncosphereoftapewormEchinococcus"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ishighlyexpressedby"/>
        <NamedIndividual IRI="member"/>
        <NamedIndividual IRI="oncosphere"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ishighlyexpressedby"/>
        <NamedIndividual IRI="member"/>
        <NamedIndividual IRI="oncosphereofcaninetapewormEchinococcus"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ishighlyexpressedby"/>
        <NamedIndividual IRI="member"/>
        <NamedIndividual IRI="oncosphereoftapewormEchinococcus"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="functionalinformation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="functionalinformationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="information"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="informationofbreast"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="informationofbreastresulting"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosisofbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT."/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldprovide"/>
        <NamedIndividual IRI="modality"/>
        <NamedIndividual IRI="informationofbreastresultingindetectiondiagnosiswithbreastCT."/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="model"/>
        <NamedIndividual IRI="significanttumorgrowthreduction"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="model"/>
        <NamedIndividual IRI="significanttumorgrowthreductioninEgKI-1-treatedmice"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="model"/>
        <NamedIndividual IRI="tumorgrowthreduction"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="model"/>
        <NamedIndividual IRI="tumorgrowthreductioninEgKI-1-treatedmice"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="showed"/>
        <NamedIndividual IRI="model"/>
        <NamedIndividual IRI="tumorgrowthreductioninmice"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="multigeneassays"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="multigeneassays"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibit"/>
        <NamedIndividual IRI="naringenin"/>
        <NamedIndividual IRI="cellgrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibit"/>
        <NamedIndividual IRI="naringenin"/>
        <NamedIndividual IRI="cellgrowthatconcentrations"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibit"/>
        <NamedIndividual IRI="naringenin"/>
        <NamedIndividual IRI="cellgrowthathigherconcentrations"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="inhibit"/>
        <NamedIndividual IRI="naringenin"/>
        <NamedIndividual IRI="cellgrowthofMCF-7cellsathigherconcentrations"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressionof"/>
        <NamedIndividual IRI="naringenintreatmentgroup"/>
        <NamedIndividual IRI="ERÎ±66"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="objective"/>
        <NamedIndividual IRI="anticanceractivitiesofO.pallidus"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="objective"/>
        <NamedIndividual IRI="antioxidantfree-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="objective"/>
        <NamedIndividual IRI="free-radicalscavenging"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="objective"/>
        <NamedIndividual IRI="free-radicalscavengingagainsthumanbreast-cancercelllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="otherpatients"/>
        <NamedIndividual IRI="Level1doses"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="review"/>
        <NamedIndividual IRI="outcomes"/>
        <NamedIndividual IRI="associationofchemotherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="review"/>
        <NamedIndividual IRI="outcomes"/>
        <NamedIndividual IRI="associationofchemotherapywithboost"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="review"/>
        <NamedIndividual IRI="outcomes"/>
        <NamedIndividual IRI="associationwithboost"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="werealsoassessedas"/>
        <NamedIndividual IRI="outcomes"/>
        <NamedIndividual IRI="excellent/good"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wereassessedas"/>
        <NamedIndividual IRI="outcomes"/>
        <NamedIndividual IRI="excellent/good"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="parameters"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="parameters"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="using"/>
        <NamedIndividual IRI="partialbreastirradiation"/>
        <NamedIndividual IRI="interstitialfractionatedhigh-dose-ratebrachytherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="averageageofwas"/>
        <NamedIndividual IRI="participants"/>
        <NamedIndividual IRI="46.34Â±8.28years"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ofageis"/>
        <NamedIndividual IRI="participants"/>
        <NamedIndividual IRI="Â±standarddeviationSD"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="diagnosedwith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="advancedbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="diagnosedwith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="breastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="found"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="appointment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hadundergone"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="breast-conservingsurgery"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hadundergone"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="surgery"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="HRpositivemetastaticbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="advancedbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="advancedrecurrentbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="hormonereceptor"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="tumorsshowing"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="ER-positive/humanepidermalgrowthfactorreceptor2-negativebreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="Level0doses"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="Level1doses"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="VMAT-SIBtechnique"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="acceleratedpartialbreastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="adjuvantacceleratedbreastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="adjuvantacceleratedpartialbreastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="adjuvantbreastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="adjuvantpartialbreastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="breastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="partialbreastirradiation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="receivedVMAT-SIBtechniquein"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="15fractions"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="receivedVMAT-SIBtechniquein"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="15fractionsfordose"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="receivedVMAT-SIBtechniquein"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="15fractionsfortotaldose"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="receivedVMAT-SIBtechniqueto"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="breast"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="receivedVMAT-SIBtechniqueto"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="wholebreast"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weredividedinto"/>
        <NamedIndividual IRI="patients"/>
        <NamedIndividual IRI="twogroupsincluding196patients"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasesteadilywith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="OPAEconcentration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasesteadilywith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="increasingOPAEconcentration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasesteadilywith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="OPAEconcentrationupto240g/mL"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasesteadilywith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="increasingOPAEconcentrationupto240g/mL"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasewith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="OPAEconcentration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasewith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="increasingOPAEconcentration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasewith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="OPAEconcentrationupto240g/mL"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="increasewith"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="increasingOPAEconcentrationupto240g/mL"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="wasfoundFor"/>
        <NamedIndividual IRI="percentcytotoxicity"/>
        <NamedIndividual IRI="celllines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="perfusion"/>
        <NamedIndividual IRI="differenttypesofbreastlesions"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canmodel"/>
        <NamedIndividual IRI="phantom"/>
        <NamedIndividual IRI="breasttissueperfusion"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Moreoverisrelatedto"/>
        <NamedIndividual IRI="polyubiquitination"/>
        <NamedIndividual IRI="ERÎ±transcriptioncycle"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isrelatedto"/>
        <NamedIndividual IRI="polyubiquitination"/>
        <NamedIndividual IRI="ERÎ±transcriptioncycle"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="posttranslationalmodificationsinteractions"/>
        <NamedIndividual IRI="coregulatorsofspecificproteincomplexes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="potentactivity"/>
        <NamedIndividual IRI="in-vitromodels"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="benefitfrom"/>
        <NamedIndividual IRI="predicting"/>
        <NamedIndividual IRI="extendedendocrinetherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="preparations"/>
        <NamedIndividual IRI="isolation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="preparations"/>
        <NamedIndividual IRI="isolationofonecompound"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="weredueto"/>
        <NamedIndividual IRI="primarysexualdysfunctions"/>
        <NamedIndividual IRI="penetrationpain"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="problems"/>
        <NamedIndividual IRI="dysfunctionalexcitement"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="proliferation"/>
        <NamedIndividual IRI="breasttumourcells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canmodel"/>
        <NamedIndividual IRI="proposeddigitalphantom"/>
        <NamedIndividual IRI="breasttissueperfusion"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canmodelbreasttissueperfusionduring"/>
        <NamedIndividual IRI="proposeddigitalphantom"/>
        <NamedIndividual IRI="4DbreastCTimageacquisition"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canmodel"/>
        <NamedIndividual IRI="proposedphantom"/>
        <NamedIndividual IRI="breasttissueperfusion"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="develop"/>
        <NamedIndividual IRI="purpose"/>
        <NamedIndividual IRI="4Ddigitalbreastphantomincludingtime-varyingcontrastenhancementforsimulationofdedicatedbreastCTperfusionimaging"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isused"/>
        <NamedIndividual IRI="randomdistribution"/>
        <NamedIndividual IRI="vary"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isused"/>
        <NamedIndividual IRI="randomdistribution"/>
        <NamedIndividual IRI="varyonvoxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="varyon"/>
        <NamedIndividual IRI="randomdistribution"/>
        <NamedIndividual IRI="voxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="varyperfusionparameterson"/>
        <NamedIndividual IRI="randomdistribution"/>
        <NamedIndividual IRI="voxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="affecting"/>
        <NamedIndividual IRI="recombinantEgKI-1"/>
        <NamedIndividual IRI="cellgrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="affecting"/>
        <NamedIndividual IRI="recombinantEgKI-1"/>
        <NamedIndividual IRI="normalcellgrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predicting"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
        <NamedIndividual IRI="benefit"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predicting"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
        <NamedIndividual IRI="benefitfromendocrinetherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="predicting"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
        <NamedIndividual IRI="benefitfromextendedendocrinetherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinked"/>
        <NamedIndividual IRI="regulator"/>
        <NamedIndividual IRI="related"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinked"/>
        <NamedIndividual IRI="regulator"/>
        <NamedIndividual IRI="relatedtoendocrinetherapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinked"/>
        <NamedIndividual IRI="regulator"/>
        <NamedIndividual IRI="relatedtotherapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinkedto"/>
        <NamedIndividual IRI="regulator"/>
        <NamedIndividual IRI="development"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinkedto"/>
        <NamedIndividual IRI="regulator"/>
        <NamedIndividual IRI="developmentofmammarytumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="alsofunctionas"/>
        <NamedIndividual IRI="related"/>
        <NamedIndividual IRI="coactivators"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="alsofunctionas"/>
        <NamedIndividual IRI="related"/>
        <NamedIndividual IRI="coactivatorsforERÎ±"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="functionas"/>
        <NamedIndividual IRI="related"/>
        <NamedIndividual IRI="coactivators"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="functionas"/>
        <NamedIndividual IRI="related"/>
        <NamedIndividual IRI="coactivatorsforERÎ±"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="repeatedchromatographicpreparations"/>
        <NamedIndividual IRI="isolation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="repeatedchromatographicpreparations"/>
        <NamedIndividual IRI="isolationofonecompound"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="repeatedpreparations"/>
        <NamedIndividual IRI="isolation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="ledto"/>
        <NamedIndividual IRI="repeatedpreparations"/>
        <NamedIndividual IRI="isolationofonecompound"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluating"/>
        <NamedIndividual IRI="research"/>
        <NamedIndividual IRI="mechanisms"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluating"/>
        <NamedIndividual IRI="research"/>
        <NamedIndividual IRI="potentialbiomarkers"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluating"/>
        <NamedIndividual IRI="research"/>
        <NamedIndividual IRI="potentialbiomarkersofresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isanticipated"/>
        <NamedIndividual IRI="research"/>
        <NamedIndividual IRI="continue"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="retrospectivestudy"/>
        <NamedIndividual IRI="women"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="retrospectivestudy"/>
        <NamedIndividual IRI="womenwithBCstreatedfrom2008to2017"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="retrospectivestudy"/>
        <NamedIndividual IRI="womenwithHER2-positiveBCstreatedwithtrastuzumab"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="retrospectivestudy"/>
        <NamedIndividual IRI="womenwithHER2-positiveBCstreatedwithtrastuzumabfrom2008to2017"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="selectiveestrogenreceptormodulators"/>
        <NamedIndividual IRI="cyclindependentkinase"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Thereforeselecting"/>
        <NamedIndividual IRI="seriousdamage"/>
        <NamedIndividual IRI="nABregimen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="selecting"/>
        <NamedIndividual IRI="seriousdamage"/>
        <NamedIndividual IRI="nABregimen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressionin"/>
        <NamedIndividual IRI="severalaspects"/>
        <NamedIndividual IRI="breastcancerpathogenesis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="upregulatedexpressionof"/>
        <NamedIndividual IRI="severalaspects"/>
        <NamedIndividual IRI="IRs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="severalclinicopathologicalparameters"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="severalclinicopathologicalparameters"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="severalparameters"/>
        <NamedIndividual IRI="laterecurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="areprognosticfor"/>
        <NamedIndividual IRI="severalparameters"/>
        <NamedIndividual IRI="recurrenceselectiontools"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressionof"/>
        <NamedIndividual IRI="showing"/>
        <NamedIndividual IRI="estrogen-responsivegenes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="expressionof"/>
        <NamedIndividual IRI="showing"/>
        <NamedIndividual IRI="genes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="highexpressionof"/>
        <NamedIndividual IRI="showing"/>
        <NamedIndividual IRI="estrogen-responsivegenes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="highexpressionof"/>
        <NamedIndividual IRI="showing"/>
        <NamedIndividual IRI="genes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="significantreduction"/>
        <NamedIndividual IRI="breastcancergrowth"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="significanttumorgrowthreduction"/>
        <NamedIndividual IRI="EgKI-1-treatedmice"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="specificproteincomplexes"/>
        <NamedIndividual IRI="ERÎ±"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="women"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="514women"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="included"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="514womenwithbreastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961onIRsignalling"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="pivotalroleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="pivotalroleonIRsignalling"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="pivotalroleonIRsignallinginMCF-7MDA-MB-231"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="roleofIRantagonistS961"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="roleofIRantagonistS961onIRsignalling"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="roleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="roleonIRsignalling"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="investigate"/>
        <NamedIndividual IRI="study"/>
        <NamedIndividual IRI="roleonIRsignallinginMCF-7MDA-MB-231"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="allowing"/>
        <NamedIndividual IRI="supportivecare"/>
        <NamedIndividual IRI="lesstoxicity"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarerequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarerequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarestillrequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarestillrequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arerequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arerequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arestillrequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arestillrequiredfor"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="existingin"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="loop"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="existingin"/>
        <NamedIndividual IRI="targets"/>
        <NamedIndividual IRI="loopTAMs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarerequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarestillrequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Howeverarestillrequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arerequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arerequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arestillrequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="furtherinvestigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arestillrequiredfor"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="investigation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="existingin"/>
        <NamedIndividual IRI="therapeutictargets"/>
        <NamedIndividual IRI="loopTAMs"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="delay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="delay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationofchemotherapylongtermoverallsurvivaldataarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="delay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationofchemotherapytermsurvivaldataarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="improve"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="outcomes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="clinic"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="oftendelay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="oftendelay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationofchemotherapylongtermoverallsurvivaldataarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="oftendelay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationofchemotherapylongtermsurvivaldataarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="oftendelay"/>
        <NamedIndividual IRI="therapies"/>
        <NamedIndividual IRI="initiationofchemotherapytermsurvivaldataarelacking"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="backboneof"/>
        <NamedIndividual IRI="therapy"/>
        <NamedIndividual IRI="treatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canreduce"/>
        <NamedIndividual IRI="therapy"/>
        <NamedIndividual IRI="recurrences"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canreduce"/>
        <NamedIndividual IRI="therapy"/>
        <NamedIndividual IRI="recurrencesoccurring"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remains"/>
        <NamedIndividual IRI="therapy"/>
        <NamedIndividual IRI="backboneincases"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remains"/>
        <NamedIndividual IRI="therapy"/>
        <NamedIndividual IRI="backboneoftreatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="remains"/>
        <NamedIndividual IRI="therapy"/>
        <NamedIndividual IRI="backboneoftreatmentincases"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="using"/>
        <NamedIndividual IRI="threevisualrepresentations"/>
        <NamedIndividual IRI="threedifferentmetricsofmortality"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="arecomputedfor"/>
        <NamedIndividual IRI="time-enhancementcurves"/>
        <NamedIndividual IRI="voxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="tolerability"/>
        <NamedIndividual IRI="ERI"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="reducing"/>
        <NamedIndividual IRI="total"/>
        <NamedIndividual IRI="poweractivities"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinked"/>
        <NamedIndividual IRI="transcriptionalregulator"/>
        <NamedIndividual IRI="related"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinked"/>
        <NamedIndividual IRI="transcriptionalregulator"/>
        <NamedIndividual IRI="relatedtoendocrinetherapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinked"/>
        <NamedIndividual IRI="transcriptionalregulator"/>
        <NamedIndividual IRI="relatedtotherapyresistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinkedto"/>
        <NamedIndividual IRI="transcriptionalregulator"/>
        <NamedIndividual IRI="development"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinkedto"/>
        <NamedIndividual IRI="transcriptionalregulator"/>
        <NamedIndividual IRI="developmentofmammarytumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="islinkedto"/>
        <NamedIndividual IRI="transcriptionalregulator"/>
        <NamedIndividual IRI="developmentoftumors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="blocked"/>
        <NamedIndividual IRI="treatment"/>
        <NamedIndividual IRI="cellcycle"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="blockedcellcyclein"/>
        <NamedIndividual IRI="treatment"/>
        <NamedIndividual IRI="G2/Mphase"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="canlose"/>
        <NamedIndividual IRI="treatment"/>
        <NamedIndividual IRI="effectiveness"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="markedlysuppressed"/>
        <NamedIndividual IRI="treatment"/>
        <NamedIndividual IRI="cellmigration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="suppressed"/>
        <NamedIndividual IRI="treatment"/>
        <NamedIndividual IRI="cellmigration"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="suppressing"/>
        <NamedIndividual IRI="treatment"/>
        <NamedIndividual IRI="transcriptionofcellcycleregulationproteins"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="Moreovershow"/>
        <NamedIndividual IRI="tumormodels"/>
        <NamedIndividual IRI="enhancementdynamics"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="evaluatedin"/>
        <NamedIndividual IRI="tumormodels"/>
        <NamedIndividual IRI="work"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="show"/>
        <NamedIndividual IRI="tumormodels"/>
        <NamedIndividual IRI="differentenhancementdynamics"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="show"/>
        <NamedIndividual IRI="tumormodels"/>
        <NamedIndividual IRI="enhancementdynamics"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="type"/>
        <NamedIndividual IRI="closedloopstructure"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hasdimensionsAs"/>
        <NamedIndividual IRI="typical4D"/>
        <NamedIndividual IRI="example"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="hasdimensionsAs"/>
        <NamedIndividual IRI="typical4Dphantom"/>
        <NamedIndividual IRI="example"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="couldoptimizepatientselectionin"/>
        <NamedIndividual IRI="understanding"/>
        <NamedIndividual IRI="setting"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isused"/>
        <NamedIndividual IRI="uniformdistribution"/>
        <NamedIndividual IRI="varyonvoxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="vary"/>
        <NamedIndividual IRI="uniformdistribution"/>
        <NamedIndividual IRI="perfusionparameters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="varyon"/>
        <NamedIndividual IRI="uniformdistribution"/>
        <NamedIndividual IRI="voxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="vary"/>
        <NamedIndividual IRI="uniformrandomdistribution"/>
        <NamedIndividual IRI="perfusionparameters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="varyperfusionparameterson"/>
        <NamedIndividual IRI="uniformrandomdistribution"/>
        <NamedIndividual IRI="voxel-basis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="upregulatedexpression"/>
        <NamedIndividual IRI="breastcancerpathogenesis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="regulates"/>
        <NamedIndividual IRI="upregulatedexpression"/>
        <NamedIndividual IRI="severalaspectsofmalignantphenotypeincludingcellproliferation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="women"/>
        <NamedIndividual IRI="HER2-positiveBCstreatedfrom2008to2017"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isin"/>
        <NamedIndividual IRI="196patients"/>
        <NamedIndividual IRI="groupAB"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="segmenting"/>
        <NamedIndividual IRI="3Dphantom"/>
        <NamedIndividual IRI="breastCTimage"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="segmentingbreastCTimagefrom"/>
        <NamedIndividual IRI="3Dphantom"/>
        <NamedIndividual IRI="healthypatientintoskinfibroglandulartissueadiposetissue"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="segmentingbreastCTimagefrom"/>
        <NamedIndividual IRI="3Dphantom"/>
        <NamedIndividual IRI="patient"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="segmentingbreastCTimagefrom"/>
        <NamedIndividual IRI="3Dstaticphantom"/>
        <NamedIndividual IRI="healthypatientintoskinfibroglandulartissueadiposetissue"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="segmentingbreastCTimagefrom"/>
        <NamedIndividual IRI="3Dstaticphantom"/>
        <NamedIndividual IRI="patient"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="3patients"/>
        <NamedIndividual IRI="Level0doses"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="received"/>
        <NamedIndividual IRI="4patients"/>
        <NamedIndividual IRI="Level1doses"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="iswith"/>
        <NamedIndividual IRI="514women"/>
        <NamedIndividual IRI="breastcancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isinducedby"/>
        <NamedIndividual IRI="ERÎ±polyubiquitination"/>
        <NamedIndividual IRI="estradiolhormone"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultingin"/>
        <NamedIndividual IRI="ERÎ±polyubiquitinationestrogenreceptordegraders"/>
        <NamedIndividual IRI="ERÎ±degradation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultingvia"/>
        <NamedIndividual IRI="ERÎ±polyubiquitinationestrogenreceptordegraders"/>
        <NamedIndividual IRI="ubiquitinproteasomesystem"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultingin"/>
        <NamedIndividual IRI="ERÎ±polyubiquitinationselectiveestrogenreceptordegraders"/>
        <NamedIndividual IRI="ERÎ±degradation"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="resultingvia"/>
        <NamedIndividual IRI="ERÎ±polyubiquitinationselectiveestrogenreceptordegraders"/>
        <NamedIndividual IRI="ubiquitinproteasomesystem"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isknown"/>
        <NamedIndividual IRI="PI3K/AKT/mTORpathway"/>
        <NamedIndividual IRI="growthpathway"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="isknown"/>
        <NamedIndividual IRI="PI3K/AKT/mTORpathway"/>
        <NamedIndividual IRI="growthpathwayinHRpositivebreastcancerPI3Kinhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="promotes"/>
        <NamedIndividual IRI="TAMs/CXCL1"/>
        <NamedIndividual IRI="breastcancermetastasis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="promotesbreastcancermetastasisvia"/>
        <NamedIndividual IRI="TAMs/CXCL1"/>
        <NamedIndividual IRI="NF-ÎºB/SOX4activation"/>
    </ObjectPropertyAssertion>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="bindsto"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="blockedexpressionin"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="causeof"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="diagnosedwith"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="inhibits"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="iscorrelatedwith"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="issignificantlycorrelatedwith"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="iswith"/>
    </FunctionalObjectProperty>
    <FunctionalObjectProperty>
        <ObjectProperty IRI="resultsin"/>
    </FunctionalObjectProperty>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="bindsto"/>
        <Class IRI="Gene"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="blockedexpressionin"/>
        <Class IRI="Chemical"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="causeof"/>
        <Class IRI="Disease"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="diagnosedwith"/>
        <Class IRI="Species"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="inhibits"/>
        <Class IRI="Other"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="iscorrelatedwith"/>
        <Class IRI="Gene"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="issignificantlycorrelatedwith"/>
        <Class IRI="Gene"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="iswith"/>
        <Class IRI="Species"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="resultsin"/>
        <Class IRI="Gene"/>
    </ObjectPropertyDomain>
    <ObjectPropertyRange>
        <ObjectProperty IRI="bindsto"/>
        <Class IRI="Gene"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="blockedexpressionin"/>
        <Class IRI="Gene"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="causeof"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="diagnosedwith"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="inhibits"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="iscorrelatedwith"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="issignificantlycorrelatedwith"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="iswith"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="iswith"/>
        <Class IRI="Gene"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="resultsin"/>
        <Class IRI="Disease"/>
    </ObjectPropertyRange>
</Ontology>



<!-- Generated by the OWL API (version 5.1.0) https://github.com/owlcs/owlapi/ -->


